InvestorsHub Logo
Followers 3420
Posts 32269
Boards Moderated 1
Alias Born 07/08/2006

Re: $heff post# 80559

Monday, 09/01/2014 9:59:29 PM

Monday, September 01, 2014 9:59:29 PM

Post# of 97239
$EXEL..Exelixis Announces Results from the COMET-1 Phase 3 Pivotal Trial of Cabozantinib in mCRPC http://t.co/7zOwM3ROLx (study failed)

Sheff's Station...All Aboard...Sign Up Here!

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.